查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863141

心臟監測設備：市場洞察、競爭格局及預測（至2032年）

Cardiac Monitoring Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

心臟監測設備市場摘要

  • 全球心臟監測設備市場預計將從 2024 年的 213.6061 億美元成長到 2032 年的 316.0255 億美元，反映出強勁且持續的成長。
  • 全球心臟監測設備市場預計在 2025 年至 2032 年的預測期內將以 5.11% 的複合年成長率成長。
  • 心臟監測設備市場的主要促進因素是心血管疾病及相關風險因素的增加、對遠端患者監護的需求不斷成長、產品設計方面的技術進步以及主要企業產品開發活動的增加。
  • 心臟監測設備市場的主要企業包括：波士頓科學公司、Neurosoft、ACS Diagnostics、美敦力、百多力、雅培、微創醫療、皇家飛利浦、通用電氣、ZOLL Medicalax、AliveCor Inc.、Bexen Cardio、iRhythm Technologies Inc.、Me-Triller GmbH、Osypka GmbH、Osypka Gmb Technologies Inc.、Me-Triller GmbH、OsypkaU​​r Technologies G​​HTE、HM. Pvt. Ltd.。
  • 由於心血管疾病高發生率、人口老化嚴重，以及對人工智慧穿戴裝置和遠端監測系統等先進技術的早期應用，北美預計將主導整個心臟監測設備市場。強大的醫療基礎設施、有利的報銷政策以及FDA對創新設備的持續核准將進一步推動市場成長。此外，市場領導者的存在以及對預防性醫療保健日益成長的重視也鞏固了該地區的領先地位。
  • 根據產品類型分類，預計到 2024 年，心臟監測設備市場將佔最大的市場佔有率。

心臟監測設備市場成長要素

  • 心血管疾病及其相關風險因素的增加推動市場擴張：肥胖、糖尿病、高血壓和缺乏運動等風險因素導致的心血管疾病日益增多，正迅速推動對心臟監測設備的需求。心臟疾病是全球主要的致病和致死原因之一，因此亟需早期發現、持續監測和預防性護理。這正推動全球先進心臟監測技術的應用日益普及。
  • 遠端患者監護需求成長推動市場發展：遠端患者監護的需求日益成長，使得病患能夠在醫院外即時持續監測心臟狀況，這顯著推動了遠端醫療監護設備市場的擴張。遠距遠端保健的興起進一步促進了這一趨勢，它有助於更好地管理慢性疾病，減少再次入院，並提高患者的便利性。穿戴式心電圖儀、心電圖貼片和植入式監視器的使用在全球範圍內不斷擴展。
  • 產品設計的技術進步：產品設計的技術進步也是市場擴張的關鍵因素。更小巧、更智慧、更人性化的解決方案，例如穿戴式心電圖貼片、人工智慧系統和無線植入式設備，正在湧現。這些創新提高了測量精度、舒適度和數據連接性，實現了即時數據共用和個人化醫療。這促使患者和醫療專業人員的接受度不斷提高，進一步推動了市場成長。

本報告檢視了全球心臟監測設備市場，並提供了市場概況、市場影響因素和市場機會分析、法律制度、市場規模趨勢和預測、按各個區隔市場、地區/主要國家進行的詳細分析、競爭格局以及主要企業的概況。

目錄

第1章：心臟監測設備市場－報告概述

  • 調查範圍
  • 市場區隔
  • 市場假設

2. 心臟監測設備市場：摘要整理

  • 市場概覽

第3章：心臟監測設備市場：關鍵因素分析

  • 市場促進因素
    • 心血管疾病及其相關危險因子的增加
    • 遠端患者監護的需求日益成長
    • 科技進步日新月異
    • 主要企業加大產品研發力度
  • 市場阻礙與課題
    • 資料隱私與安全
    • 設備相關限制
  • 市場機遇
    • 將人工智慧和機器學習應用於心臟數據解讀

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

6. 心臟監測設備市場：波特五力分析

第7章：心臟監測設備市場評估

  • 依產品類型
    • 心電圖（ECG）設備
    • 植入式循環記錄儀
    • 事件記錄器
    • 超音波心動圖（超音波心動圖）
    • 移動式心電遙測（攜帶式心臟遠端監測）
    • 其他
  • 最終用戶
    • 醫院
    • 門診手術中心
    • 居家照護機構
  • 地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

10. 心臟監測設備市場公司及產品概況

  • Boston Scientific Corporation
  • Neurosoft
  • ACS Diagnostics
  • Medtronic
  • BIOTRONIK
  • Abbott
  • Microport Scientific Corporation
  • Koninklijke Philips NV
  • GENERAL ELECTRIC COMPANY
  • ZOLL Medical Corporation
  • AliveCor Inc.
  • Bexen Cardio
  • iRhythm Technologies Inc.
  • Me-Trax GmbH
  • Osypka Medical GmbH
  • GE Healthcare
  • BIOTRONIK SE & Co. KG
  • Schiller AG
  • Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd.
  • BPL Medical Technologies Pvt. Ltd.

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明與諮詢

Product Code: DIMDCL0014

Cardiac Monitoring Devices Market Summary

  • The global cardiac monitoring devices market is expected to increase from USD 21,360.61 million in 2024 to USD 31,602.55 million by 2032, reflecting strong and sustained growth.
  • The global cardiac monitoring devices market is growing at a CAGR of 5.11% during the forecast period from 2025 to 2032.
  • The market of cardiac monitoring devices is being primarily driven by the growing instances of cardiovascular diseases and their associated risk factors, increasing demand for remote patient monitoring, technological advancements in the product designs, and an increase in product development activities among the key market players.
  • The leading companies operating in the cardiac monitoring devices market include Boston Scientific Corporation, Neurosoft, ACS Diagnostics, Medtronic, BIOTRONIK, Abbott, Microport Scientific Corporation, Koninklijke Philips NV, GENERAL ELECTRIC COMPANY, ZOLL Medical Corporation, AliveCor Inc., Bexen Cardio, iRhythm Technologies Inc., Me-Trax GmbH, Osypka Medical GmbH, GE Healthcare, BIOTRONIK SE & Co. KG, Schiller AG, Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd., and others.
  • North America is expected to dominate the overall cardiac monitoring devices market due to the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. Strong healthcare infrastructure, supportive reimbursement policies, and continuous FDA approvals for innovative devices further drive growth. Additionally, the presence of leading market players and increasing focus on preventive healthcare reinforce the region's dominant position.
  • In the product type segment of the cardiac monitoring devices market, the ECG devices category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Cardiac Monitoring Devices Market

  • Growing instances of cardiovascular diseases and their associated risk factors leading to a surge in cardiac monitoring devices: The growing instances of cardiovascular diseases, along with associated risk factors such as obesity, diabetes, hypertension, and sedentary lifestyles, are driving a surge in demand for cardiac monitoring devices. With heart conditions becoming a leading cause of morbidity and mortality globally, there is an increasing need for early detection, continuous monitoring, and preventive care, which is fueling the widespread adoption of advanced cardiac monitoring technologies.
  • Increasing demand for remote patient monitoring is escalating the market of cardiac monitoring devices: The increasing demand for remote patient monitoring is significantly escalating the market for cardiac monitoring devices, as it enables continuous, real-time tracking of heart health outside hospital settings. This trend, accelerated by telehealth adoption, supports better management of chronic conditions, reduces hospital readmissions, and improves patient convenience-driving wider use of wearable ECGs, patches, and implantable monitors worldwide.
  • Technological advancement in product design: Technological advancements in product design are boosting the cardiac monitoring devices market by introducing smaller, smarter, and more patient-friendly solutions such as wearable ECG patches, AI-powered systems, and wireless implantables. These innovations enhance accuracy, comfort, and connectivity, enabling real-time data sharing and personalized care, which in turn drives greater adoption among both patients and healthcare providers.

Cardiac Monitoring Devices Market Report Segmentation

This cardiac monitoring devices market report offers a comprehensive overview of the global Cardiac Monitoring Devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (ECG Devices [Resting ECG, Stress ECG, and Holter Monitors], Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing cardiac monitoring devices market.

A cardiac monitoring device is a medical device that helps in the monitoring of heart rhythms. There are numerous types of cardiac monitoring devices, ranging from conventional cardiac monitors to portable and even implantable cardiac monitors. These devices help in the diagnosis of heart rhythm-related disorders as well as alert patients and healthcare providers during adverse events.

The overall market for cardiac monitoring devices is being strongly boosted by the rising prevalence of cardiovascular diseases and related risk factors, which heightens the need for early detection and continuous monitoring. This demand is further amplified by the growing adoption of remote patient monitoring, allowing real-time heart health management beyond clinical settings. At the same time, technological advancements in device design, including AI integration, miniaturization, and wearables, are making solutions more accurate and patient-friendly. Additionally, increased product development activities by key players are expanding device options and accessibility, collectively driving robust market growth.

What are the latest Cardiac Monitoring Devices Market Dynamics and Trends?

The cardiac monitoring devices market is gaining momentum, driven by the rising prevalence of cardiovascular diseases (CVDs) such as heart failure and coronary artery disease, along with their associated risk factors. According to DelveInsight's analysis (2024), approximately 621 million people globally were living with heart and circulatory diseases, underscoring a vast and expanding patient pool in need of advanced monitoring solutions. By 2030, over 12.5 million people are projected to be affected by atrial fibrillation, a condition that often requires interventional support to prevent heart failure and related complications. These conditions remain among the leading causes of mortality worldwide, reinforcing the critical role of early detection and continuous monitoring in improving patient outcomes.

Cardiac monitoring devices, including ECGs, Holter monitors, implantable loop recorders, and wearable monitors, play a vital role in tracking cardiac function, identifying abnormalities, and supporting timely interventions. Coronary (ischemic) heart disease, the most common cardiovascular disorder, currently affects about 200 million people worldwide, including 110 million men and 80 million women (British Heart Foundation, 2024). The growing global burden of such conditions is directly fuelling demand for advanced cardiac monitoring technologies.

In addition, the rapid adoption of remote patient monitoring (RPM) is emerging as a major growth driver. As the need for continuous care beyond hospital settings increases, RPM solutions enable real-time monitoring of patients' heart health at home. Devices such as wearable ECG monitors, wireless Holter systems, and connected implantable recorders transmit live data to healthcare providers, ensuring early detection and timely intervention. For example, in June 2024, Endotronix received FDA Premarket Approval (PMA) for its Cordella PA Sensor System to manage NYHA Class III heart failure patients. The system remotely monitors pulmonary artery pressure alongside non-invasive vitals, enabling clinicians to optimize therapy and reduce hospitalizations. A U.S. launch is expected later this year, with CE mark review underway for European rollout. Taken together, the increasing prevalence of cardiovascular diseases, rising demand for remote monitoring, and ongoing regulatory approvals are expected to significantly drive the growth of the global cardiac monitoring devices market during the forecast period.

The future growth of the cardiac monitoring devices market faces significant challenges, particularly related to the very technology that drives it. The reliance on remote and cloud-based systems introduces critical data privacy and security concerns. As these devices collect highly sensitive health information, the risk of data breaches, unauthorized access, and cyberattacks becomes a major deterrent for both patients and healthcare providers. The fear of a security breach can lead to a lack of trust and adoption, despite the clinical benefits.

Furthermore, the devices themselves have inherent limitations related to data accuracy, reliability, and monitoring duration. Issues such as sensor error, poor connectivity, and inconsistent data transmission can compromise the integrity of the information received by clinicians. The episodic nature of some monitoring devices, as opposed to continuous, real-time tracking, can also lead to critical cardiac events "slipping through the cracks." These technical shortcomings, coupled with the need for better patient education and a seamless workflow for healthcare professionals, represent key constraints that may limit the market's full growth potential.

Cardiac Monitoring Devices Market Segment Analysis

Cardiac Monitoring Devices Market by Product Type (ECG Devices [Resting ECG, Stress ECG, and Holter Monitors], Implantable Loop Recorders, Event Recorders, Echocardiogram, Mobile Cardiac Telemetry, and Others), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product Type: ECG Devices Category Dominates the Market

In the ECG devices segment of the cardiac monitoring devices market, Holter monitors are projected to hold the largest share at around 57% in 2024, owing to their long-established role as a reliable diagnostic tool for continuous heart rhythm monitoring. Unlike standard ECGs that capture only a brief snapshot of cardiac activity, Holter monitors record data continuously for 24 to 48 hours, making them highly effective in detecting intermittent arrhythmias, silent ischemia, atrial fibrillation, and other irregularities that may not appear during routine clinical evaluations.

Clinicians favor Holter monitors because they are non-invasive, cost-effective, and widely available, positioning them as a first-line option for extended ECG monitoring. Technological advancements-such as wireless and patch-based Holter devices-have further enhanced patient comfort, compliance, and diagnostic accuracy by enabling real-time data transmission to healthcare providers and supporting faster clinical decision-making. For instance, in March 2025 at HIMSS, Peerbridge Health introduced the Cor MDx, a next-generation 3-lead, 2-channel wearable capable of detecting up to 31 arrhythmias while offering features such as 14-day Holter monitoring, mobile cardiac telemetry (MCT), and hemodynamic assessments.

Looking ahead, the integration of artificial intelligence (AI) and advanced analytics into Holter monitoring platforms is expected to transform diagnosis and disease management by improving arrhythmia detection accuracy, reducing clinician workload, and enabling predictive insights. Furthermore, greater interoperability with remote patient monitoring (RPM) platforms will expand their role in long-term disease management, especially for high-risk patients with chronic cardiovascular conditions. These advancements, coupled with sustained adoption in both hospital and ambulatory care settings, will reinforce Holter monitors' dominance in the ECG devices segment and drive their continued market growth.

By End-User: Hospitals Dominate the Market

Hospitals are boosting the cardiac monitoring devices market by serving as the primary centers for diagnosing, managing, and treating cardiovascular diseases, which remain a leading cause of mortality worldwide. With rising patient admissions for arrhythmias, heart failure, and other cardiac conditions, hospitals increasingly adopt advanced monitoring solutions such as Holter monitors, ECG machines, telemetry systems, and implantable loop recorders to ensure accurate and continuous heart monitoring. Their strong infrastructure, skilled professionals, and integration of remote patient monitoring technologies further drive demand, positioning hospitals as key contributors to the growth of the cardiac monitoring devices market.

Cardiac Monitoring Devices Market Regional Analysis

North America Cardiac Monitoring Devices Market Trends

North America is projected to account for the largest share of the global cardiac monitoring devices market, around 43% in 2024, driven by the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. The region's strong healthcare infrastructure, supportive reimbursement landscape, and continuous FDA approvals for innovative devices further reinforce its leadership position. In addition, the presence of leading market players and growing emphasis on preventive healthcare continue to strengthen market growth.

According to DelveInsight's analysis (2024), approximately 4.0% of U.S. adults had been diagnosed with coronary heart disease, while an estimated 12.2 million people were living with atrial fibrillation in 2023. Both conditions are major contributors to heart failure and other complications, underscoring the critical need for cardiac monitoring solutions that enable early detection, improved disease management, and better survival outcomes.

Awareness initiatives such as American Heart Month, led by organizations like the American Heart Association (AHA) and the CDC, are further promoting prevention, regular screenings, and continuous monitoring, thereby boosting adoption of cardiac monitoring devices. Ongoing product innovation also fuels growth. For instance, in November 2024, Fourth Frontier received 510(k) clearance for its Frontier X Plus, a single-lead continuous ECG monitor worn around the chest. The device wirelessly transmits ECG data to remote dashboards and leverages advanced algorithms to classify cardiac rhythms such as bradycardia, tachycardia, normal sinus rhythm, and atrial fibrillation.

Taken together, the high disease burden, strong technological uptake, patient awareness, and steady stream of regulatory approvals are expected to drive sustained growth of the cardiac monitoring devices market in North America.

Europe Cardiac Monitoring Devices Market Trends

Europe is driving the growth of the cardiac monitoring devices market through a combination of rising cardiovascular disease prevalence, strong healthcare infrastructure, and supportive regulatory and reimbursement frameworks. As per DelveInsight's 2023 analysis for the EU4 and UK indicated a higher prevalence of diagnosed atherosclerotic cardiovascular disease (ASCVD) cases was observed in males, nearly 12,601 thousand cases, compared to 8,645 thousand cases in females. Males typically experience ASCVD earlier and face an increased risk of coronary heart disease (CHD) relative to females. This high burden of heart and circulatory diseases has created significant demand for advanced diagnostic and monitoring solutions such as Holter monitors, implantable loop recorders, telemetry systems, and wearable ECG devices.

Additionally, European healthcare providers are increasingly adopting remote patient monitoring and digital health technologies, supported by initiatives to strengthen telemedicine and reduce hospital readmissions. For instance, in January 2024, iRhythm received CE Mark certification under the new EU Medical Device Regulation (MDR) for its next-generation Zio monitor ECG system and its accompanying ZEUS AI-based ECG analysis platform, a significant milestone reinforcing its leadership in ambulatory cardiac monitoring.

With growing investments in AI-powered monitoring, wearable technologies, and cross-border healthcare innovation, Europe continues to play a pivotal role in shaping the expansion of the cardiac monitoring devices market.

Asia-Pacific Cardiac Monitoring Devices Market Trends

The Asia-Pacific region is emerging as a major growth driver of the cardiac monitoring devices market due to a rising prevalence of cardiovascular diseases, a rapidly aging population, and increasing adoption of digital health technologies. Countries like China, India, and Japan are experiencing a surge in heart disease cases driven by lifestyle changes, urbanization, and growing risk factors such as diabetes, obesity, and hypertension. Governments and healthcare providers across the region are investing heavily in modern healthcare infrastructure and promoting remote patient monitoring to improve access to cardiac care in rural and underserved areas. Additionally, the increasing penetration of wearable and portable cardiac monitoring devices, coupled with the rising focus of global players on expanding into emerging Asian markets, is further accelerating market growth. For instance, in May 2025, iRhythm launched its Zio(R) long-term continuous ECG monitoring (LTCM) system in Japan, offering up to 14 days of continuous monitoring with deep-learning AI algorithms approved by Japan's PMDA. This provides a significant step-up from traditional Holter monitors.

Thus, the factors mentioned above are expected to boost the market of cardiac monitoring devices across the Asia-Pacific region.

Who are the major players in the cardiac monitoring devices market?

The following are the leading companies in the cardiac monitoring devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Boston Scientific Corporation
  • Neurosoft
  • ACS Diagnostics
  • Medtronic
  • BIOTRONIK
  • Abbott
  • Microport Scientific Corporation
  • Koninklijke Philips NV
  • GENERAL ELECTRIC COMPANY
  • ZOLL Medical Corporation
  • AliveCor Inc.
  • Bexen Cardio
  • iRhythm Technologies Inc.
  • Me-Trax GmbH
  • Osypka Medical GmbH
  • GE Healthcare
  • BIOTRONIK SE & Co. KG
  • Schiller AG
  • Nihon Kohden Corporation
  • BPL Medical Technologies Pvt. Ltd.
  • Others

How is the competitive landscape shaping the cardiac monitoring devices market?

The competitive landscape of the cardiac monitoring devices market is shaping up with a mix of established global players and emerging innovators, creating a highly concentrated market. Leading companies such as Medtronic, GE Healthcare, Philips Healthcare, Abbott, and Boston Scientific dominate the space with strong product portfolios in ECG devices, Holter monitors, telemetry systems, and implantable loop recorders. These firms leverage their global presence, regulatory expertise, and continuous R&D investments to maintain market leadership. At the same time, smaller and mid-sized companies, as well as startups, are intensifying competition by introducing AI-powered, wearable, and remote monitoring solutions tailored to digital health and telemedicine. Market concentration remains high in traditional ECG and Holter devices, but newer segments like wireless and wearable monitoring are more fragmented, attracting new entrants. Strategic collaborations, acquisitions, and regulatory approvals are key tactics shaping competition, while the push for remote patient monitoring and personalized healthcare is driving innovation and market expansion.

Recent Developmental Activities in the Cardiac Monitoring Devices Market

  • In July 2025, the FDA cleared the CardioTag device, which is the first wearable to simultaneously capture electrocardiogram (ECG), photoplethysmogram (PPG), and seismocardiogram (SCG) signals. This multimodal approach offers enhanced insights into cardiac mechanics and hemodynamics for noninvasive monitoring across care settings.
  • In March 2025, Sibel Health received its seventh FDA 510(k) clearance for the ANNE One wireless monitoring platform, which captures all vital signs for patients aged 12 and older, including ECG, heart rate, respiration, and more.
  • In March 2025, at HIMSS, Peerbridge Health unveiled the Cor MDx, a next-generation 3-lead, 2-channel wearable capable of detecting up to 31 arrhythmias and offering features like 14-day Holter monitoring, mobile cardiac telemetry (MCT), and hemodynamic assessments.
  • In May 2025, iRhythm launched its Zio(R) long-term continuous ECG monitoring (LTCM) system in Japan, offering up to 14 days of continuous monitoring with deep-learning AI algorithms approved by Japan's PMDA. This provides a significant step-up from traditional Holter monitors.
  • In December 2024, HeartBeam, Inc. announced that the US FDA granted 510(k) clearance for its HeartBeam system for comprehensive arrhythmia assessment. The device, a first-of-its-kind high-fidelity ECG system with a credit card-sized, cable-free design, captured heart signals from three directions to provide actionable cardiac insights.
  • In September 2024, B-Secur received FDA approval for its HeartKey Rhythm suite-AI-driven ECG signal enhancement algorithms designed to improve the quality of third-party ambulatory and consumer ECG devices, facilitating better remote cardiac monitoring accuracy.

Cardiac Monitoring Devices Market Segmentation

  • Cardiac Monitoring Devices by Product Type Exposure
  • ECG Devices
  • Resting ECG
  • Stress ECG
  • Holter Monitors
  • Implantable Loop Recorders
  • Event Recorders
  • Echocardiogram
  • Mobile Cardiac Telemetry
  • Others
  • Cardiac Monitoring Devices End-Users Exposure
  • Hospitals
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Others
  • Cardiac Monitoring Devices Geography Exposure
  • North America Cardiac Monitoring Devices Market
  • United States Cardiac Monitoring Devices Market
  • Canada Cardiac Monitoring Devices Market
  • Mexico Cardiac Monitoring Devices Market
  • Europe Cardiac Monitoring Devices Market
  • United Kingdom Cardiac Monitoring Devices Market
  • Germany Cardiac Monitoring Devices Market
  • France Cardiac Monitoring Devices Market
  • Italy Cardiac Monitoring Devices Market
  • Spain Cardiac Monitoring Devices Market
  • Rest of Europe Cardiac Monitoring Devices Market
  • Asia-Pacific Cardiac Monitoring Devices Market
  • China Cardiac Monitoring Devices Market
  • Japan Cardiac Monitoring Devices Market
  • India Cardiac Monitoring Devices Market
  • Australia Cardiac Monitoring Devices Market
  • South Korea Cardiac Monitoring Devices Market
  • Rest of Asia-Pacific Cardiac Monitoring Devices Market
  • Rest of the World Cardiac Monitoring Devices Market
  • South America Cardiac Monitoring Devices Market
  • Middle East Cardiac Monitoring Devices Market
  • Africa Cardiac Monitoring Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

AI-powered innovations and applications are transforming the cardiac monitoring devices market by enabling smarter, faster, and more precise detection and management of cardiovascular conditions. Advanced algorithms integrated into ECG devices, Holter monitors, and wearable cardiac sensors can automatically detect arrhythmias, atrial fibrillation, and other heart abnormalities with high accuracy, reducing reliance on manual interpretation. AI-driven predictive analytics help in identifying patients at risk of cardiac events before they occur, supporting preventive care and timely interventions. Cloud-based platforms powered by AI also facilitate remote patient monitoring, real-time data transmission, and automated alerts to physicians, improving continuity of care. Additionally, AI enhances workflow efficiency in hospitals by analyzing large volumes of cardiac data, reducing diagnostic errors, and optimizing treatment pathways. These innovations not only improve patient outcomes but also align with the growing shift toward personalized medicine and telehealth integration in cardiac care.

U.S. Tariff Impact Analysis on Cardiac Monitoring Devices Market:

The U.S. tariff impact on the cardiac monitoring devices market is relatively limited compared to other medical device categories, but it can still influence import costs, supply chain efficiency, and pricing strategies. Since many components and finished devices are manufactured overseas, tariffs on electronic parts, sensors, and medical equipment can raise production and procurement costs for U.S. healthcare providers and manufacturers. This may lead to higher device prices, affecting hospital budgets and patient affordability. However, strong domestic manufacturing capabilities of leading U.S. players like Medtronic, Abbott, and GE Healthcare help offset dependency on imports, reducing the overall tariff burden. In the long run, tariffs may encourage local sourcing, strategic partnerships, and innovation in domestic production, slightly reshaping the competitive dynamics of the U.S. cardiac monitoring devices market.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the cardiac monitoring devices market report study

  • Market size analysis for the current cardiac monitoring devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the cardiac monitoring devices market.
  • Various opportunities available for the other competitors in the cardiac monitoring devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current cardiac monitoring devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the cardiac monitoring devices market growth in the future?

Frequently Asked Questions for the Cardiac Monitoring Devices Market

1. What is the growth rate of the cardiac monitoring devices market?

  • The cardiac monitoring devices market is estimated to grow at a CAGR of 5.11% during the forecast period from 2025 to 2032.

2. What is the market for cardiac monitoring devices?

  • The cardiac monitoring Devices market was valued at USD 21,360.61 million in 2024, and is expected to reach USD 31,602.55 million by 2032.

3. Which region has the highest share in the cardiac monitoring devices market?

  • North America is expected to dominate the overall cardiac monitoring devices market due to the high prevalence of cardiovascular diseases, a large aging population, and the early adoption of advanced technologies such as AI-powered wearables and remote monitoring systems. Strong healthcare infrastructure, supportive reimbursement policies, and continuous FDA approvals for innovative devices further drive growth. Additionally, the presence of leading market players and increasing focus on preventive healthcare reinforce the region's dominant position.

4. What are the drivers for the cardiac monitoring devices market?

  • The overall market for cardiac monitoring devices is being strongly boosted by the rising prevalence of cardiovascular diseases and related risk factors, which heightens the need for early detection and continuous monitoring. This demand is further amplified by the growing adoption of remote patient monitoring, allowing real-time heart health management beyond clinical settings. At the same time, technological advancements in device design, including AI integration, miniaturization, and wearables, are making solutions more accurate and patient-friendly. Additionally, increased product development activities by key players are expanding device options and accessibility, collectively driving robust market growth.

5. Who are the key players operating in the cardiac monitoring devices market?

  • Some of the key market players operating in the cardiac monitoring devices market include Boston Scientific Corporation, Neurosoft, ACS Diagnostics, Medtronic, BIOTRONIK, Abbott, Microport Scientific Corporation, Koninklijke Philips NV, GENERAL ELECTRIC COMPANY, ZOLL Medical Corporation, AliveCor Inc., Bexen Cardio, iRhythm Technologies Inc., Me-Trax GmbH, Osypka Medical GmbH, GE Healthcare, BIOTRONIK SE & Co. KG, Schiller AG, Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd., and others.

Table of Contents

1. Cardiac Monitoring Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Cardiac Monitoring Devices Market Executive Summary

  • 2.1 Market at Glance

3. Cardiac Monitoring Devices Market Key Factors Analysis

  • 3.1 Cardiac Monitoring Devices Market Drivers
    • 3.1.1 Growing instances of cardiovascular diseases and their associated risk factors
    • 3.1.2 Increasing demand for remote patient monitoring
    • 3.1.3 Increase in technological advancement
    • 3.1.4 Increase in product development activities among the key market players
  • 3.2 Cardiac Monitoring Devices Market Restraints and Challenges
    • 3.2.1 Data privacy and security
    • 3.2.2 Limitations associated with the devices
  • 3.3 Cardiac Monitoring Devices Market Opportunity
    • 3.3.1 Integration of AI and machine learning for the interpretation of cardiac data

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Cardiac Monitoring Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Cardiac Monitoring Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 ECG Devices
      • 7.1.1.1 Resting ECG
      • 7.1.1.2 Stress ECG
      • 7.1.1.3 Holter Monitors
    • 7.1.2 Implantable Loop Recorders
    • 7.1.3 Event Recorders
    • 7.1.4 Echocardiogram
    • 7.1.5 Mobile Cardiac Telemetry
    • 7.1.6 Others
  • 7.2 By End-Users
    • 7.2.1 Hospitals
    • 7.2.2 Ambulatory Surgical Centers
    • 7.2.3 Homecare Settings
    • 7.2.4 Others
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.1.2 Canada Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.1.3 Mexico Cardiac Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.2 Europe
      • 7.3.2.1 France Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.2 Germany Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.3 United Kingdom Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.4 Italy Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.5 Spain Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.2.6 Rest of Europe Cardiac Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 China Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.2 Japan Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.3 India Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.4 Australia Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.5 South Korea Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.3.6 Rest of Asia-Pacific Cardiac Monitoring Devices Market Size in USD million (2022-2032)
    • 7.3.4 Rest of the World (RoW)
      • 7.3.4.1 Middle East Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.4.2 Africa Cardiac Monitoring Devices Market Size in USD million (2022-2032)
      • 7.3.4.3 South America Cardiac Monitoring Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Cardiac Monitoring Devices Market Company and Product Profiles

  • 10.1 Boston Scientific Corporation
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Neurosoft
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 ACS Diagnostics
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Medtronic
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 BIOTRONIK
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Abbott
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Microport Scientific Corporation
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Koninklijke Philips NV
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 GENERAL ELECTRIC COMPANY
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 ZOLL Medical Corporation
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 AliveCor Inc.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 Bexen Cardio
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 iRhythm Technologies Inc.
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Me-Trax GmbH
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 Osypka Medical GmbH
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 GE Healthcare
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 BIOTRONIK SE & Co. KG
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 Schiller AG
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Nihon Kohden Corporation, BPL Medical Technologies Pvt. Ltd.
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 BPL Medical Technologies Pvt. Ltd.
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Cardiac Monitoring Devices Market in Global (2022-2032)
  • Table 2: Cardiac Monitoring Devices Market in Global by Product Type (2022-2032)
  • Table 3: Cardiac Monitoring Devices Market in Global by End-User (2022-2032)
  • Table 4: Cardiac Monitoring Devices Market in Global by Geography (2022-2032)
  • Table 5: Cardiac Monitoring Devices Market in North America (2022-2032)
  • Table 6: Cardiac Monitoring Devices Market in the United States (2022-2032)
  • Table 7: Cardiac Monitoring Devices Market in Canada (2022-2032)
  • Table 8: Cardiac Monitoring Devices Market in Mexico (2022-2032)
  • Table 9: Cardiac Monitoring Devices Market in Europe (2022-2032)
  • Table 10: Cardiac Monitoring Devices Market in France (2022-2032)
  • Table 11: Cardiac Monitoring Devices Market in Germany (2022-2032)
  • Table 12: Cardiac Monitoring Devices Market in United Kingdom (2022-2032)
  • Table 13: Cardiac Monitoring Devices Market in Italy (2022-2032)
  • Table 14: Cardiac Monitoring Devices Market in Spain (2022-2032)
  • Table 15: Cardiac Monitoring Devices Market in the Rest of Europe (2022-2032)
  • Table 16: Cardiac Monitoring Devices Market in Asia-Pacific (2022-2032)
  • Table 17: Cardiac Monitoring Devices Market in China (2022-2032)
  • Table 18: Cardiac Monitoring Devices Market in Japan (2022-2032)
  • Table 19: Cardiac Monitoring Devices Market in India (2022-2032)
  • Table 20: Cardiac Monitoring Devices Market in Australia (2022-2032)
  • Table 21: Cardiac Monitoring Devices Market in South Korea (2022-2032)
  • Table 22: Cardiac Monitoring Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 23: Cardiac Monitoring Devices Market in the Rest of the World (2022-2032)
  • Table 24: Cardiac Monitoring Devices Market in the Middle East (2022-2032)
  • Table 25: Cardiac Monitoring Devices Market in Africa (2022-2032)
  • Table 26: Cardiac Monitoring Devices Market in South America (2022-2032)
  • Table 27: Competitive Landscape
  • Table 28: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Cardiac Monitoring Devices Market Drivers
  • Figure 2: Cardiac Monitoring Devices Market Restraints
  • Figure 3: Cardiac Monitoring Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in Cardiac Monitoring Devices Market
  • Figure 5: US Tariff Impact on Cardiac Monitoring Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Cardiac Monitoring Devices Market in Global (2022-2032)
  • Figure 10: Cardiac Monitoring Devices Market in Global by Product Type (2022-2032)
  • Figure 11: Cardiac Monitoring Devices Market in Global by End-User (2022-2032)
  • Figure 12: Cardiac Monitoring Devices Market in Global by Geography (2022-2032)
  • Figure 13: Cardiac Monitoring Devices Market in North America (2022-2032)
  • Figure 14: Cardiac Monitoring Devices Market in the United States (2022-2032)
  • Figure 15: Cardiac Monitoring Devices Market in Canada (2022-2032)
  • Figure 16: Cardiac Monitoring Devices Market in Mexico (2022-2032)
  • Figure 17: Cardiac Monitoring Devices Market in Europe (2022-2032)
  • Figure 18: Cardiac Monitoring Devices Market in France (2022-2032)
  • Figure 19: Cardiac Monitoring Devices Market in Germany (2022-2032)
  • Figure 20: Cardiac Monitoring Devices Market in United Kingdom (2022-2032)
  • Figure 21: Cardiac Monitoring Devices Market in Italy (2022-2032)
  • Figure 22: Cardiac Monitoring Devices Market in Spain (2022-2032)
  • Figure 23: Cardiac Monitoring Devices Market in the Rest of Europe (2022-2032)
  • Figure 24: Cardiac Monitoring Devices Market in Asia-Pacific (2022-2032)
  • Figure 25: Cardiac Monitoring Devices Market in China (2022-2032)
  • Figure 26: Cardiac Monitoring Devices Market in Japan (2022-2032)
  • Figure 27: Cardiac Monitoring Devices Market in India (2022-2032)
  • Figure 28: Cardiac Monitoring Devices Market in Australia (2022-2032)
  • Figure 29: Cardiac Monitoring Devices Market in South Korea (2022-2032)
  • Figure 30: Cardiac Monitoring Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 31: Cardiac Monitoring Devices Market in the Rest of the World (2022-2032)
  • Figure 32: Cardiac Monitoring Devices Market in the Middle East (2022-2032)
  • Figure 33: Cardiac Monitoring Devices Market in Africa (2022-2032)
  • Figure 34: Cardiac Monitoring Devices Market in South America (2022-2032)
  • Figure 35: Competitive Landscape
  • Figure 36: Startup Funding & Investment Trends